We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Office of Science and Technology Policy’s Critical and Strategic Minerals Supply Chain Subcommittee is requesting information on the “current and future production of and demand for relevant materials, concerns related to raw material availability, and overall market dynamics” in key industry sectors. Read More
Providing stronger incentives for the development and adoption of advanced medical technologies to treat common medical conditions could save the U.S. $23 billion annually by 2040, a new report concludes. Read More
The government should provide grants for public-private partnerships working to advance new medical technologies, William Murray, president and CEO of the Medical Device Industry Consortium, told lawmakers Wednesday. Read More
Failure to include women in device trials may be blocking important discoveries in new treatment modalities, CDRH says in commentary on a study published in JAMA: Internal Medicine. Read More
Uncertainty about reimbursement now trumps FDA approval as the major impediment to private funding for new medical technologies, a venture capitalist told lawmakers during a Wednesday hearing on economic and regulatory incentives to encourage device development. Read More
A chief architect of a 2007 law promoting the development of medical devices for children has asked the FDA to provide evidence the agency is making progress on meeting its goals. Read More